⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 6, 2010European Journal Of Haematology

Ki‐67 expression as a prognostic factor in diffuse large B‐cell lymphoma patients treated with rituximab plus CHOP

Dok Hyun Yoon Dae Ro Choi Heui June Ahn Shin Kim Dae Ho Lee Sang‐We Kim Bong‐Hee Park Sun Och Yoon Jooryung Huh Sang‐Wook Lee Cheolwon Suh

View at Publisher

Ask AI

Bookmark

Share

Abstract

Elevated Ki-67 expression seems to be associated with higher relapse after CR and inferior EFS in patients with DLBCL treated with R-CHOP.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yoon et al. (2010) studied this question.

synapsesocial.com/papers/69dd598c80eea7d3f699bafd https://doi.org/10.1111/j.1600-0609.2010.01467.x

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British ColumbiaPrognostic Study · 2005 · 987 citations
2CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaOriginal Research · 2002 · 5,579 citations
3Diffuse Large B-Cell LymphomaReview · 2008 · 133 citations
4Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)Original Research · 2003 · 513 citations
5Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative studyPrognostic Study · 2006 · 268 citations

More related papers

Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma2007
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.1984
Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma2006

More from European Journal Of Haematology

Efficacy and Safety of Doxorubicin–Etoposide–Methylprednisolone ( DEP )‐Based Regimens in Haemophagocytic Lymphohistiocytosis: A Systematic Review and Meta‐AnalysisSun,
Hepatitis‐Associated Aplastic Anemia in Children and Adolescents: A Comprehensive ReviewTue,